Hidradenitis Suppurativa | Incyte | INCB54707-204
Pharmaceutical Company/Sponsor:
Incyte
Code:
INCB54707-204
Title:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Type:
Interventional
Phase:
2
Condition/Disease:
Hidradenitis Suppurativa
Intervention(s)/Treatment(s):
Drug: INCB:054707 Placebo
Status:
Not Yet Recruiting
Link for Additional Information:
